Georgia, Vermont and California officials say DEA has offered little implementation guidance after marijuana moved to Schedule III for state medical programs, leaving labeling, taxes and inspections unclear.

DEA adds dedicated federal registration paths for state-licensed medical marijuana manufacturers, distributors, and testing labs, expanding beyond dispensaries amid ongoing Schedule III transition.

A landmark Phase 2 study will test smoked, high-THC flower versus placebo in 320 veteran participants with moderate to severe PTSD. Here’s what’s being studied and why it matters for DMV patients.

Rescheduling momentum is real, but tax experts say cannabis businesses may remain under 280E for the entire 2025 tax year. Here’s what that means for DMV operators and delivery services.

A website tweak sparked headlines, but TSA says nothing changed. Here’s what airport screening still means for medical patients and DMV travelers.

DEA released the marijuana rescheduling hearing transcript as ALJ Derek Julius weighs a Schedule III recommendation. Here’s what it could mean for DMV delivery compliance.

A new Nebraska Senate ad spotlights Pete Ricketts’s past line that legalization would “kill your kids,” while federal stances on rescheduling, 280E and banking keep delivery rules in flux.

Four months after President Trump urged reclassification, DOJ made a partial move on cannabis scheduling. Here’s what it could mean for delivery laws and compliance.

A little-known 1969 cannabis journal argued the core points the DEA just made on rescheduling—raising new stakes for patients, researchers, and the DMV in 2026.

Major carriers want clear federal protections to serve state-legal cannabis businesses. Here’s why that matters for delivery, couriers, and DMV operators.

Alabama health officials unanimously withdrew their objection to potential federal rescheduling of medical cannabis, while the state program continues despite cannabis remaining Schedule I under Alabama law.

Marijuana Moment obtained DEA’s 26-question list for Colorado medical operators seeking federal rescheduling protections. Here’s why it matters for delivery, transport and compliance in the DMV.

Federal rescheduling is in motion but not finished. Here’s how taxes, banking, hemp, and delivery compliance could shift—and what DC, Maryland, and Virginia should prepare for now.

Clinical trial momentum has regulators eyeing MDMA and psilocybin. Here’s how “abuse potential” factors into rescheduling talks—and what DMV readers should watch.

NORML argues federal health guidance and medical consensus point away from Schedule I. Here’s the science, policy context, and what DMV patients should watch.

Marijuana Moment reports Gov. Jared Polis granted more cannabis pardons in Colorado. Here’s what that means, plus DMV-focused compliance insights for residents and delivery operators.

As a historic federal cannabis rescheduling hearing unfolds, ATACH’s Michael Bronstein readies for the next round. Here’s what’s known—and what DMV readers should watch.

The official record for the DEA's landmark cannabis rescheduling hearing required 294 corrections, with a few critical errors flipping witness statements on THC levels and public safety, a new report shows.